Interleukin (IL)-18 is an important proinflammatory cytokine processed and released from cells of the monocyte lineage by activation of the P2X 7 receptor by extracellular adenosine 5 0 -triphosphate (ATP). We examined if a loss-of-function polymorphism of the human P2X 7 receptor (glutamic acid-496 to alanine) impairs this process. Using a whole blood-based assay, ATP-induced release of IL-18 from homozygous subjects after 120 min incubation with ATP was 42% of that from wildtype subjects. Moreover, the level of ATP-induced IL-18 release from lipopolysaccharide (LPS)-primed monocytes of homozygous subjects after 30 and 60 min incubation with ATP was 21 and 44%, respectively, of that from wild-type monocytes. Nigericin, a K þ ionophore, induced a similar release of IL-18 from monocytes of either genotype. ATP-induced ethidium þ uptake in LPS-primed, monocytes of homozygous subjects was only 11% of that in wild-type monocytes, while P2X 7 surface expression on LPS-primed, homozygous monocytes was 44% of that on wild-type monocytes.
IL-18, previously termed interferon-g-inducing factor, is an important proinflammatory cytokine released from a variety of cell types including cells of the monocyte lineage.
1,2 IL-18 shares many properties with IL-1b, however the regulation of IL-18 synthesis and its subsequent release are poorly understood. 1 Similar to IL-1b, IL-18 requires processing by caspase-1 to generate a biologically active, mature form. 3 In addition, both these cytokines lack a signal sequence and thus are released by a pathway other than the classical endoplasmic reticulum-Golgi route. 4, 5 Maturation and release of IL-18 can be initiated by extracellular ATP. Using a whole blood assay, Gabel and co-workers were the first to demonstrate that extracellular ATP could induce the release of IL-18, 6 and although a direct role for the P2X 7 purinergic receptor was not addressed, subsequent studies by others have confirmed a role for P2X 7 in this process. ATP can induce the maturation and release of IL-18 from human monocytes, a process which is blocked by an anti-P2X 7 monoclonal antibody, as well as the P2X 7 antagonist, oxidized ATP. 7 Despite the constitutive production of IL-18, ATP stimulation alone is unable to cause the maturation and release of IL-18, but requires the preincubation of monocytes with LPS. 7 This requirement for LPS however may be cell-type specific, as ATP can induce IL-18 release from human microglia in the absence of LPS priming. 8 Coincubation of isolated human peripheral blood mononuclear cells with LPS and ATP also induces the maturation and release of IL-18, a process which can be completely inhibited by the specific P2X 7 antagonist, KN-62. 9 In addition to human leukocytes, ATP can also induce the release of IL-18 from LPS-primed murine microglia. 10 We have recently described a loss-of-function singlenucleotide polymorphism at nucleotide position 1513 of the human P2X7 gene (1513A-C) that changes a glutamic acid to alanine at amino acid 496 (Glu 496 Ala) and impairs ATP-induced Ca 2 þ and ethidium þ influx, 11 as well as ATP-induced Rb þ efflux. 12 This polymorphism also impairs a number of processes downstream of P2X 7 activation including ATP-induced IL-1b release, 12 shedding of CD23 and CD62L, 12, 13 and killing of intracellular mycobacteria.
14 Therefore, we investigated if the Glu 496 Ala polymorphism also impairs ATP-induced release of IL-18 from human monocytes. Blood was taken with informed consent from normal subjects previously identified as wild type or homozygous at position 1513 (Glu 496 Ala) of the P2X7 gene 11, 15 and who were not on anti-inflammatory medication. The study was approved by the Wentworth Area Health Service Ethics Committee (Penrith, Australia), and statistical comparisons (two-tailed Student's unpaired t-test or ANOVA) were performed using SPSS 11.5 for Windows (SPSS Inc, Chicago, IL, USA).
To determine if ATP-induced IL-18 release is impaired in subjects homozygous for the Glu 496 Ala polymorphism, we initially used a blood-based assay in which ATP can induce the release of IL-18. 6 Incubation of LPS-treated blood from wild-type subjects with ATP for 2 h produced a significant release of IL-18 of 652755 pg/ml (n ¼ 8; Figure 1a ). Incubation of LPS-treated blood from homozygous subjects with ATP produced a release of IL-18 of 337720 pg/ml (n ¼ 3), which was 42% of that observed for wild-type subjects (Po0.01; Figure 1a ). Release of IL-18 from wild-type and homozygous blood in the absence of ATP was 265748 pg/ml and 174710 pg/ml, respectively, and was not significantly different between groups (P ¼ 0.31; Figure 1a ). Although ATP caused some release of IL-18 from homozygous blood, this failed to reach significance when compared to the homozygous control (P ¼ 0.14; Figure 1a ).
We next examined if ATP-induced IL-18 release is impaired from purified, LPS-primed monocytes of subjects homozygous for the Glu 496 Ala polymorphism. Incubation of monocytes isolated from wild-type subjects with ATP for 30 min produced a release of IL-18 of 259742 pg/ml (n ¼ 7; Figure 1b ). Incubation of monocytes from homozygous subjects with ATP produced a release of IL-18 of 67720 pg/ml (n ¼ 4), which was only 21% of that observed for wild-type subjects (Po0.01; Figure 1b ). Significant differences between wild-type and homozygous monocytes were also observed at a later time point. Incubation of wild-type monocytes with ATP for 60 min produced a release of IL-18 of 306752 pg/ml (n ¼ 7), while ATP incubation of homozygous monocytes produced a release of IL-18 of 138744 pg/ml (n ¼ 4), which was 44% of that observed for wild-type subjects (Po0.02; Figure 1b) . In contrast, 60 min incubation of monocytes with nigericin, which can induce the release of IL-18 from monocytes, 16 resulted in a similar release of IL-18 from wild-type and homozygote monocytes (299778 pg/ml, n ¼ 6 vs 295761 pg/ml, n ¼ 3 respectively, P ¼ 0.95; Figure 1b) . Thereby indicating that the impaired ATP-induced IL-18 release from homozygous monocytes was not due to differences in endogenous IL-18 levels or defects in the export mechanism responsible for IL-18 release. Release of IL-18 from monocytes in the absence of ATP was minimal and similar at both time points (B13 pg/ml; Figure 1b) . Similar to the blood-based assay, ATP induced some release of IL-18 from homozygous monocytes, however, this failed to reach significance when compared to the homozygous monocytes incubated in the absence of ATP and nigericin for 30 min (P ¼ 0.46) or 60 min (P ¼ 0.08; Figure 1b) .
Activation of caspase-1 is due in part to alterations in the intracellular cation milieu. 17 Although we have previously shown near complete loss of ATP-induced ethidium þ uptake in freshly isolated monocytes from subjects homozygous for the Glu 496 Ala polymorphism, 11, 12 it is unknown if homozygous monocytes treated with LPS also have reduced ATP-induced ethidium þ uptake. Therefore, we measured ATP-induced ethidium þ uptake into LPS-primed monocytes from subjects either wild type or homozygous for the Glu 496 Ala polymorphism by time-resolved flow cytometry. Figure 2a shows that ATP-induced uptake of ethidium þ into homozygous monocytes was markedly reduced when compared to monocytes from wild-type subjects (mean arbitrary units of uptake after 5 min ATP incubation of 15167598, n ¼ 4 vs 1349772689, n ¼ 6 respectively; Po0.01). The ATP-induced ethidium þ uptake in homozygous monocytes was B13-fold higher than that previously observed in freshly isolated monocytes, 12 suggesting that cultured, homozygous monocytes may have increased P2X 7 function. Therefore, the ATP-induced ethidium þ uptake over an extended period (10 min) was measured in LPS-primed, homozygous monocytes and compared to that in freshly isolated homozygous monocytes. ATP-induced ethidium þ uptake over 10 min was significantly higher in LPS-primed monocytes compared to freshly isolated monocytes Ala polymorphism was diluted with an equal volume of RPMI-1640 media (Sigma, St Louis, MO, USA) and incubated with 100 ng/ml LPS (Escherichia coli serotype 055:B5, Sigma) for 2 h and then in the presence or absence of 6 mM ATP (Sigma) for a further 2 h, before the level of IL-18 released into cell-free supernatants was measured using an human IL-18 ELISA kit (Medical and Biological Laboratories, Nagoya, Japan). (b) Peripheral blood mononuclear cells from subjects either wild type or homozygous for the Glu 496 Ala polymorphism were isolated by density gradient centrifugation (Ficoll-Paque PLUS, Uppsala, Sweden), cultured for 2 h in RPMI-1640 medium containing 10% fetal calf serum (FCS; Invitrogen, Auckland, New Zealand) (5 Â 10 6 cell/ml) and then the plastic-adherent cells were cultured for an additional 4 h in RPMI-1640 media containing 10% FCS and 100 ng/ml LPS (0.5 ml/well). The plastic-adherent cells were then cultured in the presence or absence of 3 mM ATP or 20 mM nigericin (Sigma) in RPMI-1640 medium containing 0.1% bovine serum albumin (Sigma) (0.5 ml/well) for 30 or 60 min before the level of IL-18 released into cell-free supernatants was measured by ELISA. (a, b) *Po0.01 to corresponding control sample; Figure 2b ). This increased P2X 7 function in cultured, homozygous monocytes may be the basis for the small, albeit nonsignificant, amount of IL-18 released from these cells upon incubation with ATP ( Figure 1b) .
The surface expression of P2X 7 on LPS-primed monocytes from subjects of either genotype was measured using an anti-P2X 7 monoclonal antibody 18 and flow cytometry. P2X 7 surface expression on homozygous monocytes was significantly lower than P2X 7 surface expression on monocytes from wild-type subjects (mean fluorescent intensity of 20.676.3, n ¼ 4 vs 47.078.1, n ¼ 6 respectively, Po0.05; Figure 2c) . We have previously shown that P2X 7 expression is approximately 11-fold lower on monocyte-derived macrophages homozygous for the Glu 496 Ala polymorphism than on wild-type macrophages, 11, 14 however P2X 7 surface expression does not differ on lymphocytes of either genotype, 11 suggesting that this polymorphism, in addition to loss-offunction, may affect the upregulation or retention of this receptor on the cell surface of monocytes upon activation and/or differentiation to macrophages.
There are only a few reports which detail polymorphisms in the IL-18 gene or its promoter, 19, 20 however these studies did not assess the levels of IL-18. In this study, we demonstrate that a polymorphism in the human P2X 7 receptor impairs ATP-induced IL-18 release from LPSprimed monocytes. This impaired IL-18 release is most likely due in part to a defect in K þ efflux. We have previously shown that ATP-induced 86 Rb þ (K þ ) efflux is impaired in LPS-primed monocytes homozygous for the Glu 496 Ala polymorphism, 12 a finding consistent with our observations that ATP-induced ethidium þ uptake is also impaired in LPS-primed monocytes (Figure 2a ). It should be noted, however, that it is currently unknown if a K þ efflux is necessary for ATP-induced IL-18 release. Nevertheless, a role for K þ efflux is likely given that the efflux of this intracellular cation is necessary for both caspase-1 activation, 17 as well as IL-1b release, 21, 22 and that both cytokines are presumably released via a similar mechanism. 4, 5 In addition, the K þ ionophore, nigericin, has recently been shown to cause the release of IL-18 from human monocytes. 16 Given the central role of IL-18 in immunity and inflammation, the Glu 496 Ala polymorphism 11 and other, rarer loss-of-function polymorphisms in the P2X 7 receptor 23, 24 may have clinical significance. Impaired ATPinduced release of IL-18 may play an important role in diseases where reduced or absent levels of IL-18 are known to increase susceptibility to mycobacteria and certain bacteria, and severity of septic arthritis and endotoxic shock. 1, 2 In contrast, impaired ATP-induced IL-18 release may mitigate the severity of inflammatory diseases such as colitis, autoimmune encephalyomyelitis, and some forms of arthritis, as well as ischemia-induced renal and mycocardial dysfunction. 1, 2 It is to be noted that in a model of anti-collagen antibody-induced arthritis, P2X7 gene-deleted mice have reduced incidence and severity of disease compared to wild-type controls, 25 while similar findings are observed in IL-18 knockout mice using a model of collagen-induced arthritis. 26 In P2X7 gene-deleted mice, ATP-induced release of IL-1b is impaired, 25, 27 however it has not been reported if ATP-induced release of IL-18 is also impaired. It would be of interest to assess this in these animals and its relationship to anti-collagen antibody-induced Ala polymorphism were isolated by density gradient centrifugation, cultured for 2 h in RPMI-1640 medium containing 10% FCS (1 Â 10 6 cell/ml) and then the plastic-adherent cells were cultured for an additional 4 h in RPMI-1640 media containing 10% FCS and 100 ng/ml LPS. ATP (1 mM)-induced ethidium þ uptake into (a) LPS-primed CD14 þ wild-type or homozygous monocytes or (b) freshly isolated (fresh) or LPS-primed (cultured) CD14 þ homozygous monocytes, and (c) P2X 7 receptor expression on LPS-primed CD14 þ wild-type or homozygous monocytes was measured by flow cytometry as described.
arthritis and other murine models of disease associated with IL-18.
